Targeted antioxidants as therapeutics for treatment of pneumonia in the elderly (Q91730245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

review article

1 reference

title

Targeted antioxidants as therapeutics for treatment of pneumonia in the elderly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

author name string

Stefi F Lee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

Rebecca Harris

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

Heather W Stout-Delgado

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

publication date

16 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

24 April 2020

published in

Translational Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32268130 AND SRC:MED&resulttype=core&format=json

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

24 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Healthcare utilization and cost of pneumococcal disease in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

7 January 2021

Pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Antioxidant responses to oxidant-mediated lung diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

How mitochondria produce reactive oxygen species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

NADPH oxidases in lung health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

NLRP3 Inflammasome Activation in Aged Macrophages is diminished during Streptococcus pneumoniae Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Impaired NLRP3 Inflammasome Function in Elderly Mice during Influenza Infection Is Rescued by Treatment with Nigericin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The role of oxidative damage and stress in aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Oxidative stress contributes to lung injury and barrier dysfunction via microtubule destabilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Aging: a theory based on free radical and radiation chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Oxidative stress, aging, and diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Blue journal conference. Aging and susceptibility to lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Oxidative stress response and Nrf2 signaling in aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Aging Impairs Alveolar Macrophage Phagocytosis and Increases Influenza-Induced Mortality in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

An update of the oxidation-inflammation theory of aging: the involvement of the immune system in oxi-inflamm-aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Free radicals: properties, sources, targets, and their implication in various diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Elevated exhalation of hydrogen peroxide and thiobarbituric acid reactive substances in patients with community acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Respiratory syncytial virus infection down-regulates antioxidant enzyme expression by triggering deacetylation-proteasomal degradation of Nrf2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Mitochondrial Dysfunction in Aged Macrophages and Lung during Primary Streptococcus pneumoniae Infection is Improved with Pirfenidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The biochemical basis of antioxidant therapy in critical illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Small Molecule Modulators of Keap1‐Nrf2‐ARE Pathway as Potential Preventive and Therapeutic Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Vitamin C and Community-acquired Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Vitamin C as an antioxidant: evaluation of its role in disease prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Strategies to target mitochondria and oxidative stress by antioxidants: key points and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Mitochondria-targeted antioxidants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Mitochondrial VDAC1: A Key Gatekeeper as Potential Therapeutic Target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Dual modulation of the mitochondrial permeability transition pore and redox signaling synergistically promotes cardiomyocyte differentiation from pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Physiological roles of the mitochondrial permeability transition pore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Role of coenzyme Q 10 as an antioxidant and bioenergizer in periodontal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Coenzyme q10 administration in community-acquired pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Role of Oxidative Stress and Mitochondrial Dysfunction in Sepsis and Potential Therapies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Oxidative stress and air pollution exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Peroxiredoxin 6 differentially regulates acute and chronic cigarette smoke–mediated lung inflammatory response and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Molecular composition of the alveolar lining fluid in the aging lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Vitamin E, antioxidant and nothing more

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Antioxidants, cytokines, and influenza infection in aged mice and elderly humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The immune response of aged mice to influenza: diminished T-cell proliferation, interleukin 2 production and cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Vitamin E supplementation decreases lung virus titers in mice infected with influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Pulmonary Toxicity and the Pathophysiology of Electronic Cigarette, or Vaping Product, Use Associated Lung Injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Melatonin and mitochondrial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

The effect of N-acetylcysteine on biofilms: Implications for the treatment of respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Adverse reactions to acetylcysteine and effects of overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

N-acetyl-cysteine increases the replication of Chlamydia pneumoniae and prolongs the clearance of the pathogen from mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Anti-inflammatory effects of apocynin, an inhibitor of NADPH oxidase, in airway inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Inhibition of reactive oxygen species production ameliorates inflammation induced by influenza A viruses via upregulation of SOCS1 and SOCS3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Management of the Virulent Influenza Virus Infection by Oral Formulation of Nonhydrolized Carnosine and Isopeptide of Carnosine Attenuating Proinflammatory Cytokine-Induced Nitric Oxide Production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Use of Carnosine for Oxidative Stress Reduction in Different Pathologies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Preventive Effects of Carnosine on Lipopolysaccharide-induced Lung Injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Carnosine markedly ameliorates H9N2 swine influenza virus-induced acute lung injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Statin therapy in patients with community-acquired pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002

Targeting antioxidants to mitochondria: a new therapeutic direction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.TRSL.2020.03.002